BioPharma Ambition 2020

Advances in genetic engineering

Tom Bannon, Biologics and Advanced Therapies SME, PM Group will open the Manufacturing Workshop with a talk about the Global Status of ATMP (Advanced Therapy Medicinal Product) Manufacturing. This is a key developing area and includes Cell Gene Therapy.

“Advances in genetic engineering have accelerated the development of cell gene therapies. This is having a huge impact on patients’ lives. It brings a very exciting new era to biopharmaceutical manufacturing,” said Tom Bannon.

Gene Cell Therapy will come into focus in the Manufacturing Workshop on 3rd March 2020. It will be held at NIBRT (The National Institute for Bioprocessing Research Training), UCD Fosters Avenue, Mount Merrion, Co. Dublin.

About BioPharma Ambition

BioPharma Ambition is a stage to celebrate the discovery, development, manufacture and delivery of innovative medicines and technologies for improving human health. The event is led by the industry’s representative bodies, IPHA and BPCI, and the National Institute for Bioprocessing Research and Training (NIBRT). BioPharma Ambition is supported by Enterprise Ireland, the IDA, InterTrade Ireland and Science Foundation Ireland.

Learn more about our work with cell gene therapy